13190-50-6 Usage
General Description
[p-(dimethylamino)phenyl]lithium is a chemical compound with the formula C8H11NLi. It is an organolithium reagent used in organic synthesis as a strong base and nucleophile. The compound consists of a phenyl group substituted with a dimethylamino group and a lithium atom attached to the phenyl ring. [p-(dimethylamino)phenyl]lithium is highly reactive and can be used in various reactions such as metalation, cross-coupling, and addition reactions. It is important to handle [p-(dimethylamino)phenyl]lithium with caution due to its air and moisture sensitivity, and it is typically stored and handled under inert atmospheres or in dry solvents.
Check Digit Verification of cas no
The CAS Registry Mumber 13190-50-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,1,9 and 0 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 13190-50:
(7*1)+(6*3)+(5*1)+(4*9)+(3*0)+(2*5)+(1*0)=76
76 % 10 = 6
So 13190-50-6 is a valid CAS Registry Number.
InChI:InChI=1/C8H10N.Li/c1-9(2)8-6-4-3-5-7-8;/h4-7H,1-2H3;/rC8H10LiN/c1-10(2)8-5-3-7(9)4-6-8/h3-6H,1-2H3
13190-50-6Relevant articles and documents
CATALYTIC RADIOFLUORINATION
-
Page/Page column 92, (2010/11/30)
One aspect of the present invention relates to a method of preparing radio fluorinated substituted alkyl, cycloalkyl, aryl, and alkenyl compounds. In a preferred embodiment, potassium fluoride-18 is used. Another aspect of the invention relates to arylammonium compounds containing fluorine-18 that are useful as imaging agents. In certain embodiments, the ammonium compound is a tetraaryl ammonium salt. Another aspect of the invention relates to arylsulfonium compounds containing fluorine-18 that are useful as imaging agents. In certain embodiments, the sulfonium compound is a triaryl sulfonium salt. Another aspect of the present invention relates to a method of obtaining a positron emission image of a mammal, comprising the steps of administering to a mammal a compound of the invention, and acquiring a positron emission spectrum of the mammal.